Oedema secondary to CCB Flashcards
1
Q
A 53 year old female takes amlodipine for HTN, and presents because her ankles are swollen. Her BP is 154/76 mmHg in your office, similar to home BP measurements. How would you manage this situation?
A
Impression
Bilateral lower limb oedema has a number of importantt causes. Given the amlodipine use, CCBs are known to cause the A/E of swelling in a proportion (10-12%).
Causes of bilateral lower-limb oedema
- CHF
- renal failure
- nephrotic syndrome
- liver failure
- protein losing enteropathy
Goals of Mx
- Conduct targeted assessment, screening for other red flag causes of bilateral LL oedema
- Cease or reduce dose of CB
- escalate current HTN management, likely to dual therapy and optimise dosing whilst mitigating any other CVD risk factors both pharmacologically and non-pharmacologically, consider admission for management of HTN if evidence of end-organ damage. Avoid diuresis given patients are not volume overloaded.
2
Q
HTN - History
A
History
- PC: temporal relationship to swelling and amlodipine starting, dose of amlodipine, how long oedema for, worsening/improving?
- Sx of HTN: temporal headache, visual change, frothy urine, abdo pain, N/V.
- REDS: chest pain, dry cough, dyspnoea/WOB, orthopnoea
- PMHx, cardio disease, renal disease, anything run in family?
- CVD risk factors: smoking, alcohol, obesity, sedentary,
- Meds, allergies
3
Q
HTN - Examination
A
Examination
- General appearance + vitals
- Cardiorespiratory: ?APO, sacral oedema, heart sounds
- Peripheral vascular exam
- Hydration status
- Fundoscopy
- Cranial nerves exam
4
Q
HTN - Investigations
A
Investigations
- bedside: uACR, urinalysis
- Bloods: UEC, LFT, FBC, CVD baselines (consider further Ix if ?secondaries such as plasma free metanephrines)
- Imaging: nil at this stage unless concerned re Cardio pathology, perhaps CXR is evidence of pulmonary oedema
5
Q
HTN - Management
A
Management Supportive - appropriate lifestyle changes - elevate legs - GP referral and safety-netting/ review period
Definitive
Swelling
- Cease CCB, consider switching anti-HTN agent
-